Aldebaran Capital’s AN2 Therapeutics ANTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-406,623	Closed	-$553K	–	35
2025 Q1	$553K	Buy	406,623 +62,939	+18%	+$85.6K	0.52%	27
2024 Q4	$474K	Buy	343,684 +243,184	+242%	+$336K	0.45%	29
2024 Q3	$108K	Buy	+100,500	New	+$108K	0.1%	37